Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Post by Smokey1958on Nov 19, 2021 1:20pm
379 Views
Post# 34146530

The REALITY

The REALITYThe reality is, and in spite of thoughts to the contrary, covid is not going anywhere soon. Thus rapid antigen testing is still far removed from being a bookmark in history. In fact, based on the following articles the need and demand is growing exponentially.

Take the following article for example and the Ontario governments decision to send rapid antigen tests home with every student in the province.

https://www.cp24.com/news/ontario-to-send-rapid-antigen-tests-home-with-all-2-2-million-school-children-for-winter-break-1.5671743

Then there are the manufacturing issues that can lead to a recall.

https://www.self.com/story/ellume-rapid-test-recall

The following represents a window into the concerns around American Thanksgiving. Note the high number of cases in children and the unvaccinated. As long as vaccination rates are below a certain threshold covid infections among the vaccinated and unvaccinated will continue to rise.

https://www.democratandchronicle.com/story/news/2021/11/19/monroe-county-additional-free-rapid-antigen-testing-thanksgiving-test-sites/8667889002/

....and then there's Europe, a harbinger of the reality even within countries where vaccination rates are relatively high or the dismal reality of a national lockdown if they are low.

https://www.ctvnews.ca/health/coronavirus/facing-surge-austria-will-mandate-covid-19-shots-lock-down-1.5672903

Can AcuVid be a big player amongst the giants of Pharma ....absolutely. THRMs' AcuVid has cleared all the hurdles the FDA has thrown out there and there's no reason to believe this last expectation won't be met. Imho it would seem the FDA EUA is just around the corner. Anyone who has come this far would be wise to stick it out just a while longer ....and put mechanisms in place to protect their investment ...as all investors should do.

It should be a wild ride to the end of 2021.

GLTE ....holding patiently!!!


<< Previous
Bullboard Posts
Next >>